BioNTech SE (BNTX) Current Leases (2021 - 2024)

BioNTech SE (BNTX) has 4 years of Current Leases data on file, last reported at $42.2 million in Q4 2024.

• For the quarter ending Q4 2024, Current Leases rose 39.61% year-over-year to $42.2 million; the trailing twelve-month figure through Dec 2024 stood at $42.2 million (up 39.61% YoY), and the FY2024 full-year result was $42.2 million, up 39.61% from the prior year.
• Current Leases grew to $42.2 million in Q4 2024, from $30.2 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $42.2 million in Q4 2024 to a low of $30.2 million in Q4 2023.
• A 4-year average of $35.3 million and a median of $34.3 million in 2021 frame the typical range for Current Leases.
• Across the five-year window, Current Leases slipped 17.68% in 2023 and soared 39.61% in 2024, its largest moves.
• Tracing BNTX's Current Leases over 4 years: stood at $31.9 million in 2021, then rose by 15.08% to $36.7 million in 2022, then fell by 17.68% to $30.2 million in 2023, then jumped by 39.61% to $42.2 million in 2024.
• Business Quant data shows BNTX's Current Leases at $42.2 million in Q4 2024, $30.2 million in Q4 2023, and $36.7 million in Q4 2022.